Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e896f4121141dfd628734d3ac7e969f |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
2004-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9104113feafb91e9f69ef122e70a2da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a27a418936ecdae220c08e00756c8e5 |
publicationDate |
2005-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2005287456-A |
titleOfInvention |
RAI3 gene expression inhibitor |
abstract |
Disclosed is a therapeutic agent for cancer, particularly breast cancer with poor prognosis requiring aggressive postoperative adjuvant chemotherapy. [MEANS FOR SOLVING PROBLEMS] A method for inhibiting cell growth using a substance that suppresses the expression of a gene or nucleic acid shown in any of the following (a) to (c): A nucleic acid comprising a base sequence in which one or several bases have been deleted, substituted or added in the RAI3 gene represented by the specific sequence; (c) a base complementary to the RAI3 gene represented by the specific sequence A nucleic acid that hybridizes with a sequence under stringent conditions. [Selection figure] None |
priorityDate |
2004-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |